Light Mode
$1.66 ↓ -0.01 (-0.56%) Trading Down from the previous close of $1.67, $0.04 below the day’s high of $1.70
-0.23 (-12.11%) / 6M
Momentum, market sentiment, and recent alerts
POSC reads neutral: price sits below both the 20- and 200-day averages, the 12-month move is +12.8%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Positron Corp. operates as a nuclear medicine healthcare company, which engages in the provision of cardiac positron emission tomography imaging. It operates through the Medical Equipment and Radiopharmaceuticals segments. It offers economical, end-to-end solutions for Positron Emission Tomography (PET) myocardial perfusion imaging through complementary product integration of PET imaging systems, radiopharmaceuticals, and radioisotopes. The company was founded by Roman Oliynyk on December 20, 1983 and is headquartered in North Tonawanda, NY.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.